| Horário |
Sala |
|
Atividade |
| 08:15-10:30 | Room 1 | SESSION 3: DIFFUSE GLIOMASModerator: Joab Alves Nicacio Junior (SP) Moderator: Gustavo Matos (DF)
15 | Cannabinoids in glioma treatment
15 | How should be clinical and cognitive assessment in neurooncology?
15 | Advances in patients specific brain mapping strategies
15 | Is there any role for radiosurgery in recurrent gliomas?
15 | The role of re-resection for recurrent IDHwt gliomas
15 | Neuroplasticity and neuroprotection under the radiation oncologist view
15 | Is dexamethasone still the best friend of neuro oncologist?
30 | Discussion |
| 08:15-10:30 | Room 2 | SESSION 3: SKULL BASE TUMORS
15 | Update on the genetics of pituitary adenomas and a glimpse of the future
15 | Multimodal non-surgical treatments of aggressive pituitary tumors
15 | Advancements in pituary surgery for optimal outcomes
15 | Surgical frontiers: advancements in treating craniopharyngiomas
15 | Confronting recurrence: latest insights in treatment of craniopharyngiomas
15 | Vestibular schwannomas: effectiveness and complications of SRS
15 | Vestibular schwannomas: effectiveness and complications of mircosurgery
30 | Discussion |
| 08:15-10:30 | Room 3 | SESSION 3: PEDIATRIC SUPRATENTORIAL , MIDLINE TUMORS II AND OTHERS
15 | Radiogenomics in pediatric neuro-oncologySpeaker: Luis Filipe de Souza Godoy (SP)
15 | Managment of pineal Tumors: A surgeon perspectiveSpeaker: Sergio Cavalheiro (SP)
15 | New perspectives for the treatment of intracranial Germ cell tumors
15 | Integrative approach in pediatric craniopharyngeoma managementSpeaker: Sergio Cavalheiro (SP)
15 | Choroid plexus tumors: How to treat properly?
15 | Paliative care in pediatric neuro-oncology: What is the best timing?
45 | CASE DISCUSSION PRESENTATIONPanelist: Frederico Adolfo Benevides Silva (SP) |
| 10:30-10:50 | Room 1 | BREAK |
| 10:30-10:50 | Room 2 | BREAK |
| 10:30-10:50 | Room 3 | BREAK |
| 10:50-12:00 | Room 1 | PLENARY SESSION 3
10 | Opening Session
20 | Tumor Treating Fields: current role and future directions
20 | Vaccines and IDHwt gliomas: prospects on the horizon
20 | DNA methilation profiling as a model for precision diagnosis in neurooncology |
| 10:50-12:00 | Room 2 | PLENARY SESSION 3 - ROOM 1 |
| 10:50-12:00 | Room 3 | PLENARY SESSION 3 - ROOM 1 |
| 12:00-12:15 | Room 1 | BREAK |
| 12:00-12:15 | Room 2 | BREAK |
| 12:00-12:15 | Room 3 | BREAK |
| 12:15-13:15 | Room 1 | SIMPÓSIO SATÉLITE SERVIER: NEW FRONTIRES IN LGG TREATMENT (RESTRITO PARA PRESCRITORES)
10 | LGG Clinical case
15 | Navigating Low-Grade Glioma for Neurosurgeons: Key Decision Factors and Clinical Approaches
20 | Translating recent clinical evidence in LGG into clinical practice
15 | Q&A |
| 12:15-13:15 | Room 2 | SIMPÓSIO SATÉLITE BRAINLAB: ELEMENTS SOFTWARE: NEW SRS TOOLS FOR PLANNING AND FOLLOW UP IN NEURONCOLOGYSpeaker: João Gabriel Ribeiro (SP) |
| 12:15-13:15 | Room 3 | SIMPÓSIO SATÉLITE ZEISS TUMOR WORKFLOW: RECONSIDERING THE STANDARD OF CARE IN TUMOR TREATMENTS
15 | IORT Treatment for brain tumor
15 | Oncological Neurosurgery with Fluorescein: Precision in Tumor Margins Delination
15 | Q&A |
| 13:15-13:30 | Room 1 | BREAK |
| 13:15-13:30 | Room 2 | BREAK |
| 13:15-13:30 | Room 3 | BREAK |
| 13:30-15:30 | Room 1 | SESSION 4: DIFFUSE GLIOMAS
15 | A Critical Overview of Targeted Therapies for Glioma
15 | Translational research for gliomas: future landscapes and emerging paradigm
15 | The role of CAR T cell therapy in neurooncology
15 | What we do know about non-standard of care treatments for gliomas: cannabis, antidepressants, metformin and others
15 | Bevacizumab, is there still a role for antiangiogenics in glioblastoma?
15 | The optimal timing of palliative care in glioma patients
15 | How feasible is surgery in the motor area?
15 | Discussion |
| 13:30-15:30 | Room 2 | SESSION 4: METASTASIS
15 | Clinical and radiological assessment in patients with brain metastasisSpeaker: Victor Hugo Rocha Marussi (SP)
15 | Modern concepts of surgery for brain metastasis
15 | Modern concepts of radiosurgery for brain metastasis
15 | Is there still a role for whole-brain radiation therapy for brain metastasis?
15 | Integrative treatment for melanoma brain metastasis
15 | Integrative treatment for lung cancer brain metastasis
15 | Integrative treatment for breast cancer brain metastasis
15 | Discussion |
| 13:30-15:30 | Room 3 | SESSION 4: PRESENT - FUTURE
15 | Is proton beam therapy a real deal in pediatric neurooncology?
15 | Pre-clinical studies in medulloblastoma: what is new?
15 | Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
15 | When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
15 | The Medulloblastoma initiative-
15 | Liquid biopsy for pediatric neurooncology tumors. Is it possible?
15 | Study Protocol and Perspectives: Embryonal Tumors in infants
15 | Discussion |
| 15:30-15:50 | Room 1 | BREAK |
| 15:30-15:50 | Room 2 | BREAK |
| 15:30-15:50 | Room 3 | BREAK |
| 15:50-17:30 | Room 1 | PLENARY SESSION 4
20 | Medulloblastoma treatment in children and adolescents: From radiogenomics to molecular biology
20 | Intracranial Germ cell tumors: North American or European, What is the best approach?
20 | Immunotherapy in gliomas: is there a path ahead?
20 | Oncolytic viruses for treatment of gliomas
20 | Is Vorasidenib a real deal for IDHmt gliomas? |
| 15:50-17:30 | Room 2 | PLENARY SESSION 4 - ROOM 1 |
| 15:50-17:30 | Room 3 | PLENARY SESSION 4 - ROOM 1 |
| 17:30-18:30 | Room 1 | ORAL PRESENTATIONS AND ABSTRACTS AWARDS
30 | Oral Presentations
20 | Absracts Awards
10 | Acknowledgement and Closure
acessar trabalhos |
| 17:30-18:30 | Room 2 | ORAL PRESENTATIONS AND ABSTRACTS AWARDS - ROOM 1 |
| 17:30-18:30 | Room 3 | ORAL PRESENTATIONS AND ABSTRACTS AWARDS - ROOM 1 |
